Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Boast

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Brain Research|March 1, 1988
The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbilsC A Boast, S C Gerhardt, G Pastor, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1991
Biochemical and behavioral characterization of a novel cholinergic agonist, SR 95639C A Boast, S Leventer, A Sabb, et al.
Progress in Clinical and Biological Research|January 1, 1990
CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic propertiesD A Bennett, J Lehmann, P S Bernard, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modellingA L Sabb, G M Husbands, J Tokolics, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonistA C Bartolomeo, H Morris, J J Buccafusco, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Brain Research|March 1, 1988
The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbilsC A Boast, S C Gerhardt, G Pastor, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1991
Biochemical and behavioral characterization of a novel cholinergic agonist, SR 95639C A Boast, S Leventer, A Sabb, et al.
Progress in Clinical and Biological Research|January 1, 1990
CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic propertiesD A Bennett, J Lehmann, P S Bernard, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modellingA L Sabb, G M Husbands, J Tokolics, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonistA C Bartolomeo, H Morris, J J Buccafusco, et al.
Pageof 3